PT Phapros, Tbk
PEHA.JK
Get informed when a big investor buys or sells
+ FollowMarket Cap$241.92B
Close$
Share Statistics
| Market cap | $241.92 Billion |
|---|---|
| Enterprise Value | - |
| Dividend Yield | $5.01 (1.74%) |
| Earnings per Share | $33.37 |
| Beta | 0.4 |
| Outstanding Shares | 840,000,000 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | 5.91 |
|---|---|
| PEG | 8.54 |
| Price to Sales | 0.24 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About PT Phapros, Tbk
1,255 employees
CEO: Intan Abdams Katoppo PT Phapros, Tbk is a prominent Indonesian company operating within the pharmaceutical and healthcare sectors. Its operations are broadly categorized into four key divisions: Over-the-Counter (OTC) products, Ethical drugs, Generic drug ma...